Progressive multifocal leukoencephalopathy causes: Difference between revisions
| Line 12: | Line 12: | ||
* [[Belimumab]] | * [[Belimumab]] | ||
* [[Ciclosporin]] | * [[Ciclosporin]] | ||
* [[Ofatumumab]] | |||
* [[Ruxolitinib]] | * [[Ruxolitinib]] | ||
* [[Vedolizumab]] | * [[Vedolizumab]] | ||
Revision as of 21:20, 4 February 2015
|
Progressive multifocal leukoencephalopathy Microchapters |
|
Differentiating Progressive multifocal leukoencephalopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Progressive multifocal leukoencephalopathy causes On the Web |
|
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy causes |
|
Progressive multifocal leukoencephalopathy causes in the news |
|
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Causes
The cause of PML is a type of polyomavirus called the JC virus (JCV), after the initials of the patient in whom it was first discovered. The virus is widespread, with 86% of the general population presenting antibodies, but it usually remains latent, causing disease only when the immune system has been severely weakened.